{"id":5891,"date":"2022-04-29T18:25:57","date_gmt":"2022-04-29T18:25:57","guid":{"rendered":"https:\/\/www.ariadnelabs.org\/annualreport\/?page_id=5891"},"modified":"2023-10-16T18:17:15","modified_gmt":"2023-10-16T18:17:15","slug":"supporters-advisory-board","status":"publish","type":"page","link":"https:\/\/www.ariadnelabs.org\/2022annualreport\/supporters-advisory-board\/","title":{"rendered":"Supporters & Advisory Board"},"content":{"rendered":"\n

Our Supporters<\/h1>\n\n\n\n

This list includes grants and donors with gifts and pledges totaling $50,000 or more during our 2022 fiscal year (October 1, 2021 and September 30, 2022).<\/p>\n\n\n\n

\n
\n

Anonymous (multiple)
Bill & Melinda Gates Foundation
Blue Shield of California
Boston University School of Public Health (C3)
Branta Foundation
CaroNova
Charina Fund
Commonwealth Fund
Constellation, Inc.
Corewell Health (previously Beaumont Health)
CRICO
Donner Foundation
Gordon & Betty Moore Foundation
Grail
Harvard Medical School
Harvard Pilgrim Healthcare
Hillman Foundation
John Maraganore
Klarman Family Foundation
Liberty Mutual
<\/p>\n<\/div>\n\n\n\n

\n

Mass Eye and Ear Infirmary
Merck for Mothers
National Philanthropic Trust
Noora Health Systems
Peterson Center for Healthcare
Point32Health
Population Reference Bureau
Robert Wood Johnson Foundation
Sabin Vaccine Institute
Star Legacy
Surgo
The Board of Regents of the University of Oklahoma
The Boston Foundation
The Pew Charitable Trusts
Thompson Family Foundation
University of Washington
USAID
World Health Organization
Yellow Chair Foundation<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Advisory Board<\/h1>\n\n\n\n

Our Advisory Board includes world-class leaders in science, education, health care, and business. They support Ariadne Labs by contributing expertise on research priorities, scientific plans, implementation approaches, and collaborations<\/p>\n\n\n\n

\n
\n

PAUL J. ANDERSON, MD, PHD<\/strong>
K. Frank Austen Professor of Medicine,
Harvard Medical School
Associate Chief of the Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\u2019s Hospital.<\/p>\n\n\n\n

DONALD M. BERWICK, MD, MPP, FRCP<\/strong>
President Emeritus and Senior Fellow,
Institute for Healthcare Improvement
Former Director of Medicaid and Medicare

KATE CALVIN<\/strong>
Executive Dean for Administration,
Harvard T.H. Chan School of Public Health<\/p>\n\n\n\n

ELLIOT COHEN, MBA<\/strong>
Co-founder and Chief Product Officer,
PillPack<\/p>\n\n\n\n

ANDREW DREYFUS
<\/strong>Former President and Chief Executive Officer,
Blue Cross Blue Shield of Massachusetts<\/p>\n\n\n\n

PETER HECHT, PHD<\/strong>
CEO, Cyclerion Therapeutics<\/p>\n\n\n\n


<\/p>\n<\/div>\n\n\n\n

\n

ROBERT S.D. HIGGINS, MD, MSHA<\/strong>
President, Brigham and Women\u2019s Hospital
Executive Vice President, Mass General Brigham<\/p>\n\n\n\n

KARIN S. LESCHLY, MD, FAAFP
<\/strong>Medical Director of Quality Improvement and Population Health,
East Boston Neighborhood Health Center<\/p>\n\n\n\n

AMBASSADOR ROMAN F. MACAYA
<\/strong>Menschel Senior Leadership Fellow,
Harvard T.H. Chan School of Public Health

JOHN M. MARAGANORE, PHD<\/strong>
Founding CEO, Alnylam<\/p>\n\n\n\n

JASON YEUNG, MPHIL
<\/strong>Managing Director and Portfolio Manager, Morgan Stanley<\/p>\n\n\n\n

GWILL E. YORK, MBA
<\/strong>Co-Founder,
Lighthouse Capital Partners

<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n
\n
<\/div><\/div>\n\n
\n\n
\n
< Financials<\/a><\/div>\n<\/div>\n\n<\/div><\/div>\n\n
\n\n
\n
Home ><\/a><\/div>\n<\/div>\n\n<\/div><\/div>\n\n
<\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Our Supporters This list includes grants and donors with gifts and pledges totaling $50,000 or more during our 2022 fiscal year (October 1, 2021 and September 30, 2022). Anonymous (multiple)Bill & Melinda Gates FoundationBlue Shield of CaliforniaBoston University School of Public Health (C3)Branta FoundationCaroNovaCharina FundCommonwealth FundConstellation, Inc.Corewell Health (previously Beaumont Health)CRICODonner FoundationGordon & Betty Moore … Read more<\/a><\/p>\n","protected":false},"author":10,"featured_media":6405,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-5891","page","type-page","status-publish","has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/5891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/comments?post=5891"}],"version-history":[{"count":6,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/5891\/revisions"}],"predecessor-version":[{"id":7406,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/pages\/5891\/revisions\/7406"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/media\/6405"}],"wp:attachment":[{"href":"https:\/\/www.ariadnelabs.org\/2022annualreport\/wp-json\/wp\/v2\/media?parent=5891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}